Agoracom Blog Home

Posts Tagged ‘CBD’

Tetra Bio-Pharma Achieves DTC Eligibility in the United States $TBP.ca

Posted by AGORACOM-JC at 8:35 AM on Wednesday, November 16th, 2016

Tbp_large

  • Effective November 13, 2016, it has secured Depository Trust Company (DTC) eligibility for its common shares listed on the OTCPINK Market
  • Securities that are eligible to be electronically cleared and settled through the DTC are considered “DTC eligible”.

OTTAWA, ONTARIO–(Nov. 16, 2016) - Tetra Bio-Pharma Inc. (“TetraBio” or the “Company“) (CSE:TBP) (CSE:TBP.CN) (OTC PINK:GRPOF) is pleased to announce that effective November 13, 2016, it has secured Depository Trust Company (DTC) eligibility for its common shares listed on the OTCPINK Market.

Securities that are eligible to be electronically cleared and settled through the DTC are considered “DTC eligible”. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors.

The Company’s common shares are listed for trading on the OTCPINK, a U.S. based securities trading system, under the symbol “GRPOF”. Tetra Bio-Pharma shares will continue to be traded on the Canadian Stock Exchange under its existing symbol “TBP”.

André Rancourt, Chief Executive Officer, commented, “We’re pleased to announce that our shares have become DTC eligible on the U.S. market and excited to bring our Company to the attention of the investment community in the U.S. We believe that GRPOF offers investors a unique opportunity to invest in a bio pharmaceutical cannabis company before entering clinical trials later this year.

In other company news

Website:

The Company is proud to announce that its website located at www.tetrabiopharma.com is now live. We encourage investors to sign up for news releases and notifications as more information is added to the website.

Industry Participation:

Dr. Guy Chamberland, Chief Scientific Officer and regulatory affairs, and Ryan Brown, co-founder and VP of Business Development, will be presenting at the World of Cannabis business summit in Las Vegas on November 16th 2016. Dr. Chamberland will be presenting as part of “the science of medical cannabis” program while Ryan Brown will be presenting at the “emerging brands investor pitch seminar” more info can be found at www.worldofcannabissummit.com.

Investor Relations:

The Company would like to inform investors that it has engaged Alpha Deal Group LLC, a New York based buy side analyst firm, to perform investor analysis for presentation to its investment network.

As released on November 9, 2016, via CFN (Cannabis Financial Network), the Company has engaged Cannabis Financial Network to increase its visibility in the United States retail investment market.

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer
Phone: (613) 421-8402

Ryan Brown
Co-founder and Director of Communications
Phone: (613) 421-8402

Andre Audet
Executive Chairman
Phone: (613) 421-8402

hempSMART.com is now live, products can be purchased, check it out! $MCOA.us

Posted by AGORACOM-JC at 6:24 PM on Monday, November 7th, 2016

hempSMART.com is now live, products can be purchased!

  • Formulated to promote brain health
  • Combines enhanced memory/cognitive function benefits with the additional benefits offered by CBD

Watch Our Recent Video

TRADE DATA!!! $MCOA.us +278% in Just 6 Trading Days

Posted by AGORACOM-JC at 4:53 PM on Thursday, November 3rd, 2016

15233_mcoa

MCOA: OTC

Marijuana Could Be The Big Winner On November 8th

  • Pot on the ballot in nine states, the big winner in next Tuesday’s election could be America’s legal cannabis industry.
  • By 2020, legal market sales are expected to surpass $22 billion.
  • For states struggling with budget shortfalls, that extra revenue would be clearly welcome.

MCOA Hub on AGORACOM / Corporate Profile / Watch Video

Marijuana Could Be The Big Winner On November 8th $MCOA.us

Posted by AGORACOM-JC at 12:33 PM on Thursday, November 3rd, 2016

  • Pot on the ballot in nine states, the big winner in next Tuesday’s election could be America’s legal cannabis industry.
  • By 2020, legal market sales are expected to surpass $22 billion.
  • For states struggling with budget shortfalls, that extra revenue would be clearly welcome.

MCOA Hub on AGORACOM / Corporate Profile / Watch Video

Tetra Bio-Pharma Announces Acquisition of Intellectual Property for the Development of Natural Health Products Through Its Agro-Tek Subsidiary $TBP.ca

Posted by AGORACOM-JC at 8:35 AM on Wednesday, October 26th, 2016

Tbp_large

  • Announced that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa
  • Recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content

OTTAWA, ONTARIO–(Oct. 26, 2016) - Tetra Bio-Pharma Inc. (“Tetra Bio” or the “Company“) (CSE:TBP)(CSE:TBP.CN), through its subsidiary, Agro-Tek Inc. (“AGTK“), is pleased to announce that it has acquired multiple intellectual property assets related to the initiation of manufacturing and distribution of products for natural health care including products containing extracts or oils derived from Cannabis sativa.

The recently announced awarding of the NSERC Engage partnership grant with McGill University will allow AGTK to achieve its commercial strategy to launch Cannabis-derived supplements that comply with the existing regulations regarding cannabis and cannabinoid content. According to the United States Food and Drug Administration (“FDA“), “FDA is not aware of any evidence that would call into question its current conclusion that cannabidiol products are excluded from the dietary supplement definition under section 201(f)(3)(B)(ii) of the Federal Food, Drug, & Cosmetics Act.”

Mr. André Rancourt, the Company’s CEO commented, “CBD or THC containing dietary supplements are currently not allowed on the USA market. However, the goal of the McGill University partnership is the development of extracts of the plant Cannabis sativa, including THC and CBD-free for the development of dietary supplements.” AGTK intends on manufacturing and commercializing supplements, food-type products and, natural health products that are compliant with Canadian and USA federal regulations. Mr. Rancourt added, “This commercial strategy involves the expertise of two of the Company’s subsidiaries, AGTK and MMP, and is in line with the Company’s vision to make AGTK and MMP leaders in the development of Cannabis sativa, derived products for the consumer market, and for the commercialization of natural supplements derived from Cannabis sativa.”

The assets acquired include proprietary formulations that have obtained marketing approval from Health Canada. The line consists of:

1. Glucose Aid; NPN 80058089

2. Kava Kava; NPN 80061986

3. Stress Ado; NPN 80065911

4. Toux Ado (Cough Ado); NPN 80065923

5. Toux enfant (Cough Children); NPN 80065928

6. Water Relax; NPN 80065948 (beverage supplement)

7. Water Cough; NPN 80066086 (beverage supplement)

8. Sleep Pro; NPN 80066679

9. Instant Relief; NPN 80066682 (topical gel for local pain relief).

The acquisition of these formulations and their proprietary ingredients will provide PhytoPain Pharma Inc. with an inventory of compounds and elements that will be used as secondary ingredients or catalysts in the formulation of our pharmaceutical grade products.

In consideration for the acquisition of the assets, the Company has issued 1,800,000 common shares to arms’ length individuals. The shares issued will be subject to a four-month hold period.

According to Mr. Rancourt, these products will allow AGTK to begin generating revenues. This is the first set of products for AGTK’s portfolio. The company will be seeking to acquire additional product lines for distribution in North America. AGTK is engaged in negotiations to acquire national distributors to expand brand identity and facilitate distribution across North America

The Canadian Securities Exchange (CSE) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Andre Rancourt
Chief Executive Officer

Ryan Brown
VP Business Development and Communications

Andre Audet
Executive Chairman
(613) 421-8402
Investors@tetrabiopharma.com

Marijuana Company of America Q4 2016 Outlook and Update $MCOA.us

Posted by AGORACOM-JC at 8:46 AM on Tuesday, October 18th, 2016

15233_mcoa

 

  • hempSMART Brain product release imminent
  • Offers brain support and protection
  • Product is first-of-its-kind
  • Fulfillment center prepared to manage distribution of orders
  • Members signing up for PreLaunch

BONSALL, CA–(Marketwired – Oct 18, 2016) –

MARIJUANA COMPANY OF AMERICA INC., (“MCOA” or the “Company”) (OTC PINK:MCOA), an innovative cannabis and hemp marketing and distribution company, is providing this update to keep our shareholders and prospective investors informed.

Our first product, hempSMART BRAIN, formulated with CBD or Cannabidiol as the core ingredient combined with high quality, clinically proven, branded ingredients to compliment the CBD to support brain health. There are new articles published daily regarding the benefits of CBD, hempSMART BRAIN was formulated to meet the growing demand for cannabinoid based neutraceutical products that assist in brain function.

The hempSMART Brain product is scheduled for release by the end of October. It was expected to ship by the second week of October, but delays in receiving key ingredients from suppliers has pushed back the ship date by approximately two weeks. Our fulfillment center is ready to manage distribution of orders and they are working very closely with hempSMART’s manufacturer, which will result in significant efficiencies of scale.

hempSMART Brain is a first-of-its-kind product. The synergistic blend of clinically verified natural brain support ingredients, blended with water soluble CBD, enables crossing of the blood-brain barrier to provide optimal brain support and protection.

hempSMART Brain was developed to address the increase in neurologic and neurodegenerative challenges that have prompted a surge in scientific research on prevention and/or reversal of brain and nervous system pathology. A variety of natural products have been shown, in clinical trials, to improve neurological and cognitive function and there has been a surge of products being marketed to improve brain function.

Marketing leaders are currently preparing for the Brain product roll-out. The hempSMART prelaunch website: hempSMART.com is now active and accessible to the Company’s members.

According to the Direct Selling Association, in 2015 over 20 million people in the U.S. were involved in direct selling, with total sales of $36.1 billion. More than 74 percent of the American public has purchased goods or services through direct selling. Worldwide sales are also strong with more than $154 billion in sales. This marketing and distribution method is incredibly effective at creating solid sales and loyal members, as well as brand awareness in the marketplace because the sales “force” are people that passionately believe in the company, product and the difference it can make in people’s lives. The energy they can invest into the education of potential customers is far more than any other sales model.

Another key driver in the affiliate marketing industry is compensation or commission that is based on performance. Affiliate leaders earn rewards and compensation for developing training systems for their personal sales “teams” within hempSMART. Based on this win-win business model, companies can grow rapidly due to the success of the customer, the affiliate and the entire direct sales process.

Over the years, thousands of affiliate marketing teams have been established to promote new products for launch. Our affiliate marketing leaders are well established, long-term professionals. They are testing the system as well as preparing their marketing organizations for the Brain product launch. The Company has a robust affiliate marketing program that is integrated into the hempSMART.com full website which was designed and developed by ApogeeINVENT. This user-friendly platform will help our affiliates track their commissions and provide resources, and helpful information for marketing the Company’s products.

“We have received significant interest in this product and we are looking forward to updating the financial markets and our shareholders as the product release takes place,” said CEO, Donald Steinberg.

The Club Harmoneous pilot program has been extended due to regulatory challenges under the current non-profit regulatory model in California. The Company will continue to work through these challenges to develop a unique operating model that can operate under the current regulatory framework as well as the upcoming licensing and regulatory structure proposed by the Medical Marijuana Regulation and Safety Act (MMRSA). The Company is also prepared for the passing of Prop 64 in November for the adult use of marijuana in California. The Company continues to work closely with Green Dot Collective in Los Angeles County to overcome some of the regulatory challenges and changes in California. Upon satisfactory completion of the Southern California pilot program, the Company will begin expansion to Northern California and other legal adult use and medical marijuana states.

Investors are invited to visit the MCOA IR Hub on Agoracom to post questions and receive answers, or review questions and answers already posted by fellow investors. In addition, the MCOA IR HUB provides a monitored forum for investors and prospective shareholders to communicate within a clean, professional environment.
On behalf of the Board of Directors,

“Donald Steinberg”
Donald Steinberg
President & CEO
888-777-4362
MarijuanaCompanyofAmerica.com

About Marijuana Company of America, Inc.,
Marijuana Company of America (“MCOA”) is a publicly traded company headquartered in Southern California. MCOA will distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.

About hempSMART
The hempSMART brand represents MCOA’s non-THC, hemp derived, product line. All hempSMART products are formulated with a cannabinoid base that is derived from hemp and has less than a .3% THC content.

About Club Harmoneous
Club Harmoneous (The Club) delivers all of the benefits of cannabis to its members harmoneously. The Club provides a wide range of cannabis products to its members, medicinal, adult use or healthy foods, body care and cosmetics. The Club products are top-quality and offered to members at competitive prices with the convenience of home delivery.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana Company of America, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE
Marijuana Company of America Inc. will provide management services that assist legal businesses to cultivate, sell, and distribute hemp and marijuana based products within the legal guidelines of individual states and international markets. hempSMART products are derived from Hemp and contain than a .3% THC content.
For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
Harmoneous.com
agoracom.com/ir/MarijuanaCompanyofAmerica

CONTACT INFORMATION

  • Contact InformationDonald Steinberg
    President & CEO
    888-777-4362
    MarijuanaCompanyofAmerica.com

Marijuana Company of America Announces PreLaunch of HempSMART Brain: a Hemp Derived CBD Product to Support Brain Function $MCOA.us

Posted by AGORACOM-JC at 8:39 AM on Tuesday, October 4th, 2016

15233_mcoa

  • Cutting Edge Research and Premium Botanical Ingredients
  • Company Expects To Ship Orders in October

BONSALL, CA–(Oct 4, 2016) – MARIJUANA COMPANY OF AMERICA (OTC PINK: MCOA) –

MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, is pleased to announce the prelaunch of the hempSMART Brain product has commenced.

“We are very excited to announce the hempSMART Brain prelaunch as we prepare to begin shipping orders in the coming weeks. A lot of time and energy went into developing this product and we are looking forward to getting it into the hands of our customers,” said CEO, Donald Steinberg.

hempSMART Brain was developed to address the increase in neurologic and neurodegenerative challenges that have prompted a surge in scientific research on prevention and/or reversal of brain and nervous system pathology. A variety of natural products have been shown, in clinical trials, to improve neurological and cognitive function and there has been a surge of products being marketed to improve brain function. While the efficacy of some of these blends has been impressive, many utilize trace amounts of therapeutic ingredients, inadequate for any clinical effect.

Advantages Of HempSMART Brain Over Competing Brain Function Products

HempSMART Brain is unique in that it utilizes a synergistic blend of natural neuroprotective and neuroregenerative compounds, all in clinically researched and verified therapeutic amounts. The Core Ingredients for this product are CBD, Astaxanthin, Phosphoryl Choline and Phosphatidyl Serine. Together, these ingredients promote and support brain function and neurogenesis. Additional natural compounds compliment the synergistic effects of the core ingredients.

HempSMART exemplifies the practical application of cutting edge research and premium botanical ingredients, in therapeutic amounts. HempSMART Brain is the first of its kind. The synergistic blend of clinically verified natural brain support, with water soluble CBD, crosses the blood-brain barrier and offers brain support and protection not previously available in the marketplace.

Sales and Marketing Efforts Anticipate Pre-Orders Within Weeks

The hempSMART prelaunch website: www.hempSMART.com is now active and accessible by the Company’s members. Direct Sales leaders have been invited to join our prelaunch and begin referring others. This prelaunch will provide an indication of initial demand as orders are booked in the coming weeks, enabling management to adjust the manufacturing pipeline accordingly. The hempSMART Brain product is currently in production and is expected to ship in October 2016.

Investors are invited to visit the MCOA IR Hub on Agoracom to post questions and receive answers, or review questions and answers already posted by fellow investors. In addition, the MCOA IR HUB provides a monitored forum for investors and prospective shareholders to communicate within a clean, professional environment.

On behalf of the Board of Directors,
“Donald Steinberg”
Donald Steinberg
President & CEO
888-777-4362
MarijuanaCompanyofAmerica.com

About Marijuana Company of America Inc.

Marijuana Company of America (“MCOA”) is a publicly traded company headquartered in Southern California. MCOA will distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.

About hempSMART

The hempSMART brand represents MCOA’s non-THC, hemp derived, product line. All HempSmart products are formulated with a cannabinoid base that is derived from hemp and has less than a .3% THC content.

About Club Harmoneous

Club Harmoneous (The Club) delivers all of the benefits of cannabis to its members harmoneously. The Club provides a wide range of cannabis products to its members, medicinal, adult use or healthy foods, body care and cosmetics. The Club products are top-quality and offered to members at competitive prices with the convenience of home delivery.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana Company of America, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Marijuana Company of America Inc. will provide management services that assist legal businesses to cultivate, sell, and distribute hemp and marijuana based products within the legal guidelines of individual states and international markets.

For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
Harmoneous.com
agoracom.com/ir/MarijuanaCompanyofAmerica

Contact Information

Donald Steinberg
President & CEO
888-777-4362
MarijuanaCompanyofAmerica.com

Marijuana Company of America Launches HempSmart Brand and Begins Manufacturing Its First Proprietary CBD Brain Health Product $MCOA.us

Posted by AGORACOM-JC at 7:12 AM on Thursday, August 25th, 2016
15233_mcoa

  • First HempSmart branded CBD based product called “HempSmart BRAIN,” has entered manufacturing process;
  • Formulated to promote brain health;
  • Combines nootropic benefits with the additional benefits offered by CBD;
  • Shipments expected by September 30, 2016

BONSALL, CA–(Aug 25, 2016) – MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC PINK: MCOA)

MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, and its subsidiary (H Smart, Inc.) are pleased to announce the launch of the HempSmart brand and line of products. The first HempSmart branded CBD based product called “HempSmart BRAIN,” formulated to promote brain health, has entered the manufacturing process and is expected to ship by September 30, 2016.

This is a “first-of-a-kind, patent pending” new product that combines nootropic benefits with the additional cognitive enhancing benefits offered by CBD. Our team has developed a unique proprietary product with a water-soluble CBD base to enhance bioavailability that includes supporting ingredients that are proven cognitive enhancers.

With the expected release of the HempSmart BRAIN product next month, our marketing team is gearing up for an upcoming pre-launch. This pre-launch will enable management to access demand prior to the actual ship date and adjust the manufacturing pipeline accordingly.

“Over the years, I have successfully launched several new products into the marketplace. I feel this product line will absolutely surpass any product rollout I have done before. With the team we have in place, I am confident in a strong U.S. rollout, followed up by a global outreach,” said Mr. Steinberg, MCOA President.

The Company will initiate the pre-launch program approximately two weeks prior to the expected ship date of HempSmart’s BRAIN product. The HempSmart Division will utilize the growing Direct Sales industry as the method of product education and sales to consumers. Active participants in the direct sales program at HempSmart will be able to participate in a competitive, transparent and potentially lucrative compensation package in which members are rewarded for their sales and team’s performance.

“After more than 30 years in the Health and Wellness Industry, I can attest that these ultra-pure, all natural products will forever change the paradigm of nutritional supplementation. Backed by solid science, HempSmart technology harnesses the powerful synergy of premium bioavailable ingredients. Pairing the compelling benefits of legal organic hemp with other scientifically validated organic & highly bioavailable botanicals raises the bar in the nutritional supplement world,” said Paula Vetter, a seasoned and highly respected Certified Herbalist that serves as Chair of MCOA’s Medical Advisory Board.

Regarding the new product launch, Justin Davis, M.D., a member of the Company’s Medical Advisory Board stated, “As a physician and an athlete, I believe strongly in the optimization of mind and body. The HempSmart BRAIN product has the some of the most potent and beneficial ingredients to be found in a single formulation, and is my personal choice in my quest to protect and promote my own neural function.”

On behalf of the Board of Directors,

“Donald Steinberg”
Donald Steinberg
President & CEO
888-777-4362
www.MarijuanaCompanyofAmerica.com

About Marijuana Company of America, Inc.

Marijuana Company of America (“MCOA”) is a publicly traded company headquartered in Southern California. MCOA will distribute marijuana and products related to marijuana as well as CBD and hemp, using a variety of marketing approaches to distribute on a global basis.

About HempSmart

The HempSmart brand represents MCOA’s non-THC, hemp derived, product line. All HempSmart products are formulated with a cannabinoid base that is derived from hemp and has less than a .3% THC content.

About Club Harmoneous

Club Harmoneous (The Club) delivers all of the benefits of cannabis to its members harmoneously. The Club provides a wide range of cannabis products to its members, medicinal, adult use or healthy foods, body care and cosmetics. The Club products are top quality and offered to members at competitive prices with the convenience of home delivery.

Through MCOA’s Managed Services, the Company offers Marketing Services designed to increase membership. This is done through an affiliate referral program where members refer new member patients and earn discounts and income from their referrals. The Club Harmoneous Network Affiliate Program breaks down all of the barriers to entry and opens up the industry to individuals who might not find opportunity elsewhere. The Club provides training and a platform for those seeking an opportunity to build their own home based cannabis business. For more information go to: www.Harmoneous.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Marijuana Company of America, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Marijuana Company of America, Inc. will provide management services that assist legal businesses to cultivate, sell, and distribute hemp and marijuana based products within the legal guidelines of individual states and international markets.

For more information, please visit the company’s website at:

www.MarijuanaCompanyofAmerica.com
www.Harmoneous.com

Donald Steinberg
President & CEO
888-777-4362
www.MarijuanaCompanyofAmerica.com

V-Love(tm) now available in London Drugs stores

Posted by AGORACOM-JC at 9:06 AM on Monday, June 29th, 2015

  • V-LoveTM is now available for purchase in 30 London Drugs stores and is to be in all 79 stores by Friday July 3rd
  • First shipment of V-LoveTM to the London Drugs main distribution facility in Richmond, BC was received and is in the process of being redistributed to all London Drugs stores across Western Canada

VANCOUVER, BC / June 29 2015 – Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce V-LoveTM is now available for purchase in 30 London Drugs stores and is to be in all 79 stores by Friday July 3rd.

The first shipment of V-LoveTM to the London Drugs main distribution facility in Richmond, BC was received and is in the process of being redistributed to all London Drugs stores across Western Canada.

V-LoveTM can also be purchased online at Londondrugs.com for your personal convenience and can be shipped anywhere in Canada.

V-LoveTM is pH balanced specifically for women and provides lubrication and a moisturizing feeling to sooth vaginal dryness.


Click Image To View Full Size

V-LoveTM It all begins with desire…

“We are very pleased to be in a growing number of stores and look forward to growing our V-Love TM brand name,” stated President Robert McAllister.

About Enertopia

The Company’s mission is to empower people with a better way of living through healthy lifestyle choices in helping you live your life your way. Our core values of honesty, integrity, and commitment help to define our corporate practices and demonstrate our dedication in helping individuals whether they are encountering health issues based on age, diet or have suffered a traumatic physical, mental or an emotional event.

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that V-Love TM will have any meaningful impact on the Company or the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Enertopia signed with London Drugs: V-Love ™ to be in stores soon

Posted by AGORACOM-JC at 8:34 AM on Monday, June 22nd, 2015

  • Announced it has signed with London Drugs Ltd. to sell V-LoveTM in all their 79 stores across Western Canada.
  • Soon to be available to the consumer in all London Drug Stores across Western Canada.
  • first shipment to the London Drugs main distribution facility in Richmond, BC has been received

VANCOUVER, BC / TheNewswire / June 22 2015 – Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce it has signed with London Drugs Ltd. to sell V-LoveTM in all their 79 stores across Western Canada.

V-LoveTM will soon be available to the consumer in all London Drug Stores across Western Canada. Our first shipment to the London Drugs main distribution facility in Richmond, BC has been received.

V-LoveTM will also be available at Londondrugs.com online store for shipping across Canada.


Click Image To View Full Size

“We are very pleased to be working with London Drugs, a respected community leader and name synonymous with consumer products,” stated President Robert McAllister.

About London Drugs

Founded in 1945, B.C.-based London Drugs has 79 stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan and Manitoba, including its online store www.londondrugs.com, London Drugs offers consumers a range of products from digital cameras and cosmetics to computers and televisions. Renowned for its creative approach to retailing, the company employs more than 7,500 people with pharmacy and health care services being the heart of its business. Committed to innovation and superior customer service, London Drugs has established itself as a reputable and caring company and continues to position itself for future growth and development.

About Enertopia

We are a company with the mission to empower people with a better way of living through healthy lifestyle choices in helping you live your life your way. Our core values of honesty, integrity, and commitment help to define our corporate practices and demonstrate our dedication in helping individuals whether they are encountering health issues based on age, diet or have suffered a traumatic physical, mental or emotional event.

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that V-Love TM will have any meaningful impact on the Company or the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.